JP2021523145A5 - - Google Patents

Info

Publication number
JP2021523145A5
JP2021523145A5 JP2020562639A JP2020562639A JP2021523145A5 JP 2021523145 A5 JP2021523145 A5 JP 2021523145A5 JP 2020562639 A JP2020562639 A JP 2020562639A JP 2020562639 A JP2020562639 A JP 2020562639A JP 2021523145 A5 JP2021523145 A5 JP 2021523145A5
Authority
JP
Japan
Prior art keywords
liposome
optionally
mass
lipid mixture
approximately
Prior art date
Application number
JP2020562639A
Other languages
English (en)
Japanese (ja)
Other versions
JP7525162B2 (ja
JPWO2019217593A5 (https=
JP2021523145A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/031385 external-priority patent/WO2019217593A1/en
Publication of JP2021523145A publication Critical patent/JP2021523145A/ja
Publication of JP2021523145A5 publication Critical patent/JP2021523145A5/ja
Publication of JPWO2019217593A5 publication Critical patent/JPWO2019217593A5/ja
Priority to JP2024110694A priority Critical patent/JP2024160224A/ja
Application granted granted Critical
Publication of JP7525162B2 publication Critical patent/JP7525162B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020562639A 2018-05-08 2019-05-08 磁性リポソームおよび関連する治療ならびにイメージング方法 Active JP7525162B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024110694A JP2024160224A (ja) 2018-05-08 2024-07-10 磁性リポソームおよび関連する治療ならびにイメージング方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862668608P 2018-05-08 2018-05-08
US62/668,608 2018-05-08
PCT/US2019/031385 WO2019217593A1 (en) 2018-05-08 2019-05-08 Magnetic liposomes and related treatment and imaging methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024110694A Division JP2024160224A (ja) 2018-05-08 2024-07-10 磁性リポソームおよび関連する治療ならびにイメージング方法

Publications (4)

Publication Number Publication Date
JP2021523145A JP2021523145A (ja) 2021-09-02
JP2021523145A5 true JP2021523145A5 (https=) 2022-04-08
JPWO2019217593A5 JPWO2019217593A5 (https=) 2022-04-08
JP7525162B2 JP7525162B2 (ja) 2024-07-30

Family

ID=66677229

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020562639A Active JP7525162B2 (ja) 2018-05-08 2019-05-08 磁性リポソームおよび関連する治療ならびにイメージング方法
JP2024110694A Pending JP2024160224A (ja) 2018-05-08 2024-07-10 磁性リポソームおよび関連する治療ならびにイメージング方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024110694A Pending JP2024160224A (ja) 2018-05-08 2024-07-10 磁性リポソームおよび関連する治療ならびにイメージング方法

Country Status (6)

Country Link
US (1) US20210077399A1 (https=)
EP (1) EP3790533A1 (https=)
JP (2) JP7525162B2 (https=)
AU (1) AU2019265707B2 (https=)
CA (1) CA3099519A1 (https=)
WO (1) WO2019217593A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020037102A1 (en) 2018-08-15 2020-02-20 University Of Florida Research Foundation, Inc. Methods of sensitizing tumors to treatment with immune checkpoint inhibitors
EP3962521A1 (en) 2019-05-02 2022-03-09 University of Florida Research Foundation, Inc. Compositions for treatment of diffuse intrinsic pontine glioma
EP3999034A4 (en) * 2019-07-19 2023-08-23 University Of Florida Research Foundation, Incorporated Multilamellar rna nanoparticles
EP4099988A4 (en) * 2020-02-05 2024-03-13 University of Florida Research Foundation, Incorporated Rna-loaded nanoparticles and use thereof for the treatment of cancer
WO2022036231A1 (en) * 2020-08-14 2022-02-17 University Of Florida Research Foundation Biocompatible nanocomposite hydrogel immunotherapy vaccines and methods of use thereof
CN114848840B (zh) * 2022-03-24 2023-08-29 北京福纳康生物技术有限公司 修饰的铁基纳米材料、铁基纳米脂质体及其抗肿瘤的应用
CN119470536B (zh) * 2024-11-03 2025-09-30 中国科学院精密测量科学与技术创新研究院 利用多核磁共振预测氟化脂质纳米颗粒转染效率的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA195563A (en) 1919-08-08 1919-12-30 Aaron Terry Heating system
US7001614B2 (en) * 1996-08-19 2006-02-21 The United States Of America As Represented By The Department Of Health And Human Services Liposome complexes for increased systemic delivery
US6413544B1 (en) 1996-08-19 2002-07-02 The United States Of America As Represented By The Department Of Health And Human Services Liposome complexes for increased systemic delivery
NZ592917A (en) * 2003-09-15 2012-12-21 Protiva Biotherapeutics Inc Stable polyethyleneglycol (PEG) dialkyloxypropyl (DAA) lipid conjugates
AU2006304790B2 (en) 2005-10-20 2013-06-27 Georgetown University Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
WO2011112597A1 (en) * 2010-03-08 2011-09-15 Northeastern University Magnetic nanoplatforms for theranostic and multi-modal imaging applications
KR20150078952A (ko) * 2013-12-31 2015-07-08 삼성전자주식회사 활성 성분 및 조영제를 포함하는 리포좀 및 그의 용도
US20170367982A1 (en) * 2016-06-24 2017-12-28 Northwestern University High density lipoprotein functionalized magnetic nanostructures

Similar Documents

Publication Publication Date Title
JP2021523145A5 (https=)
Hua et al. Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo-and radiotherapy
Li et al. Tumor-targeted delivery of siRNA by self-assembled nanoparticles
Tang et al. pH/ATP cascade-responsive nano-courier with efficient tumor targeting and siRNA unloading for photothermal-immunotherapy
JP2025173509A (ja) 核酸の送達のための改善された脂質ナノ粒子
Chen et al. Dexamethasone prodrugs as potent suppressors of the immunostimulatory effects of lipid nanoparticle formulations of nucleic acids
Tagami et al. Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA
US11717480B2 (en) Extracellular vesicles and methods and uses thereof
JP7784155B2 (ja) Ｒｎａプラスミド送達システム及びその使用
CN114306279A (zh) 基于科罗索酸或其类似物的脂质纳米颗粒系统及其制备方法和应用
Kang et al. Large, anionic liposomes enable targeted intraperitoneal delivery of a TLR 7/8 agonist to repolarize ovarian tumors’ microenvironment
US20240141361A1 (en) Gene circuit, rna delivery system and use thereof
Zhang et al. STING‐activating polymers boost lymphatic delivery of mRNA vaccine to potentiate cancer immunotherapy
CN115297850A (zh) 用于肝纤维化和其他与纤维化相关的疾病的基于外排体的治疗
US20180369273A1 (en) Pharmaceutical Composition and Applications Thereof
EP3675871A1 (en) Compositions and methods for the treatment of fibrotic diseases
WO2025200517A1 (zh) 一种用于核酸递送的脂质材料及其用途
JPWO2019217593A5 (https=)
JP2024511808A (ja) ウイルスベクターに基づくｒｎａ送達システム及びその使用
Muktapuram et al. Anticancer siRNA delivery by new anticancer molecule: a novel combination strategy for cancer cell killing
CN113403313B (zh) 一种特异识别人PLK1位点的sgRNA、质粒、纳米复合物和应用
CN113786391A (zh) 一种mRNA递送系统及其制备方法和应用
Alaaeldin et al. Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules
Wang et al. Self-assembled immunostimulatory nanosphere combined with PD-L1 to enhanced cancer chemoimmunotherapy
Zhao et al. Nucleic acid-based nanogels with “offensive and defensive” effects for enhanced chemo-immunotherapy